SK

Shoman Kasbekar

Principal at Foresite Capital

United States

Overview 

Shoman Kasbekar is a Principal at Foresite Capital, with a background in biotechnology and healthcare. He has held various roles in investment firms and companies like Rare Genomics Institute and Synthego Corporation, showcasing expertise in strategic partnerships and technology commercialization. Kasbekar's career highlights include his current role as Principal at Foresite Capital, where he focuses on investing in various sectors within healthcare and biotechnology, and his experience in strategic partnerships at Rare Genomics Institute, demonstrating a strong background in the industry.

Work Experience 

FC

Foresite Capital

  • Principal

    2022 - Current

    Foresite is a venture capital fund investing in people and discoveries that can transform biotechnology and healthcare. Investing $5-100M checks, $4B AUM.

  • Senior Associate

    2021 - 2022

  • Associate

    2020 - 2021

Foresite Capital is a healthcare and life sciences investment firm.

foresitecapital.com
RG

Rare Genomics Institute

  • Strategic Partnerships

    2018

    Building alliances with life sciences, medical device, and healthcare companies to increase the impact of RGI’s initiatives to help individuals suffering from rare diseases.

SC

Synthego Corporation

  • Senior Manager, Strategy & BD

    2020 - 2020

    Synthego was founded to revolutionize CRISPR genome editing technology, helping to translate genomics into the clinic and make engineered biological therapies accessible to all patients.

  • Manager, Strategy & BD

    2019 - 2020

  • Associate

    2018 - 2019

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Raised $459,694,663.00 from AAF Management Ltd., RA Capital Management, Laurion Capital Management, Moore Strategic Ventures, Wellington Management, Logos Capital, Chimera Investment, Gigafund, Perceptive Advisors and Declaration Partners.

synthego.com
DI

DaVita Inc.

  • Senior Analyst

    2016 - 2018

    Drove partnerships for DaVita's $5B+ commercial business. Executed special projects across healthcare reform, market entry/expansion, and value-based care. Redwoods Leadership Program.

Provide hemodialysis, peritoneal dialysis, and acute care to acute renal failure patients, chronic kidney disease patients.

davita.com
SI

Sharecare, Inc.

  • Corporate Development Analyst

    2015 - 2015

    M&A diligence, analytics, and commercial strategy in digital health.

Sharecare is a health and wellness engagement platform that provides information, programs, and resources to improve individuals health.

Raised $850,000,000.00 from Baron Capital, Woodline Partners, Digital Alpha, Elevance Health, Koch Strategic Platforms and Eldridge Industries.

sharecare.com
VT

Vanderbilt Technology Transfer & Commercialization

  • Technology Commercialization/Transfer Analyst

    2014 - 2015

    Monetization of Vanderbilt intellectual property in medtech/biotech.

Education 

Articles About Shoman

Relevant Websites